The following information was generated from the 
Developmental and Reproductive Toxicology Database (DART),
 on July 28, 2017.

Query: The chemical name bisphenol f was identified.
The following terms were added from ChemIDplus:
unii dkn2t8syhu
CAS Registry Number: 1333-16-0
The chemical name bisphenol f was identified.

### OH en ortho position (donc pas exactement BPF)
The following terms were added from ChemIDplus:
2 2  bisphenol f
2 2  methylenediphenol
CAS Registry Number: 2467-02-9

### OH en para position (donc pas exactement BPF)
The chemical name bisphenol f was identified.
The following terms were added from ChemIDplus:
phenol  4 4  methylenebis 
4 4  bisphenol f
4 4  methylenediphenol
CAS Registry Number: 620-92-8



1 - DART
TITLE:
      A new chapter in the bisphenol A story: bisphenol S and bisphenol F are
      not safe alternatives to this compound.

AUTHORS:
      Eladak S
         Unit of Genetic Stability, Stem Cells, and Radiation, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontx-Ry-aux-Roses, France; Criat … ie Atomie Atomique, FontenaFontenay-aux-Roses, France; InNational de la Sant‚ etRecher Recherche Merche M‚dicaleeacnit‚ 967, Fontenay-aux-Roses, France.
      Grisin T
         Unit oic StabStem Cells, Cells, and Radiation, LaboratLaboratory of Development of the Gonads, Universit‚ Parrot, derot, Sorbonne Paris Cit‚,ay-aux-Ry-aux-Roses, France; Commissariat … l'En, Foque, Fontenay-aux-Roses, France; Institut Natiut National de la Sant‚la Rech&eche M‚dicute;dUcale, Unit‚ 967nay-atenay-aux-Rosnce.
      Moison D
         Unit of Get of Genetic Stability, Stem Cells, aation, Laion, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, France; Commissariat … l'Energie Atomique, Fontenay-aux-Roses,  Institut National de la  de la Sant‚ e Recher Recherche M&eacute, Unit&e Unit‚ 967, Foatenay-aux-Roses, France.
      Guerquin       Un     Unit of Genetic Stability, Stem Cells, and Radiation, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, France; Commissagrave; l'Energie Atomique, Fontenay-aux-Ry-aux-Roses, France; Institut l de la Sde la Sant‚ et de la Recherche M‚dicaleeacnit‚ 967, Fontenay-aux-Roses, France.
      N'Tumba-Byn T
   nit of Geneticity, Stem C Stem Cells, and Radiation, Laion, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, France; Commissariat … le Atomique, Fontenay-aux-ay-aux-Roses, France; Institut National de la Sant&eat de la Recherche M‚dicale, Unit&e Unit‚ 967, Foatenay-aux-Roses, France.
      Pozzi-Gaudin S
         Service de Gyn&cologie-Obst‚trique et M&e et M‚decine ep la Reproduction, H“pital A. B‚clŠre, Universit‚ Paris Sud, Clamarte.
       Benachi A
         Service de Gyn&eacyn‚cologieacbst‚trique et M&decine decine de la Reproduction, H“pital A. B‚clŠrersit‚ PariClamd, ClamartClamart, France.
      Livera G
         UnieneticStabilim Cells, and Radiad Radiation, Ltion, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, France; Commissariat … l'Energie Atomiqtenay-aux-Roses, France; Institut National de lal de la Sant‚ a he M&e he M‚dinit&, Unit&, Unit‚ 967, Fontenay-aux-Roses, France  Rouilre V
     
         Unit of Genetic Static Stability, Stem Cells, andion, Labon, Laboratory of Development of the Gonads, Universit‚ iderot, derot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, FCommissariat … l'Energie Atomique,omique, Fontenay-aux-Roses, Frnstitut National de la Sae la Sant‚ et echer Recherche M‚dicale, Unit‚ ntenay-atenay-aux-Roses, France.
      Habert R
  Unit of Genebility, Stem Cells, and Radand Radiation,iation, Laboratory of Development of the Gonads, Universit‚ Paris Diderot, Sorbonne Paris Cit‚, Fontenay-aux-Roses, France; Commissariat &agravergie Atomique, Fontenay-atenay-aux-Roses, France; Institut National de la Sant‚ et de lr Recherche M‚dinit&eacnit‚ 967,ay-atenay-aux-Roses, France. Electronic address: rene.habert@cea.fr.

S
      Fertil Steril. 2015, Jan;5, Jan; 103(1):11-21. [Fertility and sterility]

ABSTRACT:
      Bisphenol A (BPA) is a widely studied typical endocrine-disrupting
      chemical, and one of the major new issues is the safe replacement of this
      commonly used compound. Bisphenol S (BPS) and bisphenol F (BPF) are
      already or are planned to be used as BPA alternatives. With the use of a
      culture system that we developed (fetal testis assay [FeTA]), we
      previously showed that 10 nmol/L BPA reduces basal testosterone secretion
      of human fetal testis explants and that the susceptibility to BPA is at
      least 100-fold lower in rat and mouse fetal testes. Here, we show that
      addition of LH in the FeTA system considerably enhances BPA minimum
      effective concentration in mouse and human but not in rat fetal testes.
      Then, using the FeTA system without LH (the experimental conditions in
      which mouse and human fetal testes are most sensitive to BPA), we found
      that, as for BPA, 10 nmol/L BPS or BPF is sufficient to decrease basal
      testosterone secretion by human fetal testes with often nonmonotonic
      dose-response curves. In fetal mouse testes, the dose-response curves were
      mostly monotonic and the minimum effective concentrations were 1,000
      nmol/L for BPA and BPF and 100 nmol/L for BPS. Finally, 10,000 nmol/L BPA,
      BPS, or BPF reduced Insl3 expression in cultured mouse fetal testes. This
      is the first report describing BPS and BPF adverse effects on a
      physiologic function in humans and rodents.

KEYWORDS:
      BPA
      BPF
      BPS
      Bisphenol A
      Insl3
      Leydig cells
      bisphenol F
      bisphenol S
      endocrine disruptors
      environmental health
      fetus
      human
      organotypic culture
      species differences
      testis
      testosterone

CAS REGISTRY NUMBERS:
      80-09-1
      MLT3645I99

LANGUAGE:
      eng

INTERNATIONAL STANDARD SERIAL NUMBER:
      1556-5653 (Electronic)

PUBLICATION TYPES:
      Comparative Study

      Journal Article

      Research Support, Non-U.S. Gov't

      Review

ENTRY MONTH:
      201501

TITLE ABBREVIATION:
      Fertil Steril

YEAR OF PUBLICATION:
      2015

LAST REVISION DATE:
      20150101

COPYRIGHT INFORMATION:
      Copyright &copy; 2015 The Authors. Published by Elsevier Inc. All rights
      reserved.

MEDLINE CITATION:
      NLM

COUNTRY:
      United States

CITATION SUBSET:
      IM

MEDLINE TITLE ABBREVIATION:
      Fertility and sterility

ARTICLE DATE:
      20141202

STAT:
      MEDLINE

DOCUMENT NUMBER:
      medline/25475787

2 - DART
TITLE:
      Hazard identification and risk characterization of bisphenols A, F and AF
      to aquatic organisms.

AUTHORS:
      Ti&scaron;ler T
         Laboratory for Environmental Sciences and Engineering, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia. Electronic address: tatjana.tisler@ki.si.
      Krel A
         Chair of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, A&scaron;ker&#269;eva 7, SI-1000 Ljubljana, Slovenia.
      Ger&#382;elj U
         Chair of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, A&scaron;ker&#269;eva 7, SI-1000 Ljubljana, Slovenia.
      Erjavec B
         Laboratory for Environmental Sciences and Engineering, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia.
      Dolenc MS
         Chair of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, A&scaron;ker&#269;eva 7, SI-1000 Ljubljana, Slovenia.
      Pintar A
         Laboratory for Environmental Sciences and Engineering, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia.

SOURCE:
      Environ Pollut. 2016, May; 212:472-9. [Environmental pollution (Barking,
      Essex : 1987)]

ABSTRACT:
      Production of bisphenol A (BPA) analogues such as bisphenol F (BPF) and
      bisphenol AF (BPAF) has recently increased, due to clear evidence of
      adverse effects of BPA on humans and wildlife. Bisphenols (BPs) have
      already been released into aquatic environment without previous available
      information about potential adverse effects of BPs and their potential
      risk to aquatic ecosystems. In this study, lethal and sublethal effects of
      BPF and BPAF to bacteria, algae, crustacea and fish embryos were
      investigated and the results were compared to the adverse effects obtained
      for BPA. We found that BPAF was the most toxic compound to Daphnia magna,
      Danio rerio and Desmodesmus subspicatus; the lowest 72      h EC50 (median
      effective concentration) and 21      d NOEC (no observed effect
      concentration) values were determined at 2.2      mg/L regarding zebrafish
      hatching success and 0.23      mg/L of BPAF obtained for growth and
      reproduction of water fleas, respectively. In most cases, BPA was more
      toxic to D.      magna, D.      rerio and D.      subspicatus in
      comparison to BPF, but pigmentation of zebrafish embryos after 48      h
      of exposure and reproduction of water fleas after 21-day D.      magna
      reproductive test exposure to BPF were much more impaired. Risk quotients
      (measured environmental concentration/21      d NOEC) showed that BPA, BPF
      and BPAF are recently not chronically hazardous to the survival,
      reproduction and growth of water fleas in surface waters. On the other
      hand, we importantly show that currently present BPAF concentrations in
      surface waters could cause a potential ecological risk to aquatic
      organisms. In the near future, higher concentrations of BPF and BPAF in
      surface waters are anticipated and for this reason further testing using
      test systems with various aquatic species and endpoints are needed to
      provide additional information about toxic impacts of BPF and BPAF on
      aquatic biota. 

KEYWORDS:
      Acute toxicity
      Bisphenols
      Chronic toxicity
      Lethal effects
      Risk quotient
      Sublethal endpoints

CAS REGISTRY NUMBERS:
      MLT3645I99

LANGUAGE:
      eng

INTERNATIONAL STANDARD SERIAL NUMBER:
      1873-6424 (Electronic)

PUBLICATION TYPES:
      Journal Article

ENTRY MONTH:
      201605

TITLE ABBREVIATION:
      Environ Pollut

YEAR OF PUBLICATION:
      2016

LAST REVISION DATE:
      20170110

COPYRIGHT INFORMATION:
      Copyright &copy; 2016 Elsevier Ltd. All rights reserved.

MEDLINE CITATION:
      NLM

COUNTRY:
      England

CITATION SUBSET:
      IM

MEDLINE TITLE ABBREVIATION:
      Environmental pollution (Barking, Essex : 1987)

ARTICLE DATE:
      20160305

STAT:
      MEDLINE

DOCUMENT NUMBER:
      medline/26957022

3 - DART
TITLE:
      Bisphenol A induces otolith malformations during vertebrate embryogenesis.

AUTHORS:
      Gibert Y
         Institut de G‚nomique Fonctionnelle de Lyon; Universit‚ de Lyoer Universit‚ LyRA; EcNRA; Ecole Normale Sup‚rieure deeure de Lyon; 46 all‚lie, yon 4 Lyon Cedex 07, France France. vincent.laudet@ens-lyon.fr
      Sassi-Mess        Institut de G&eace G‚nomnctiononctionnelle de Lyon; Universit‚ de Lyon; Universit‚ Lyon ; ICNRS; INRA; Ecoale Sup&ee Sup‚rieure de Lyon; 46 all‚e d'Ital6e, 69364 Lyon CedFrance. vance. vincent.laudet@ens-lyon.fr
      Fini JB
         Institut dete;nomiqu;nomique Fonctionnelle de Lyon; Universit‚ de Lyon; Universit‚ Lyon 1; CNRS; INRA; Ecole Normale Sup‚ri46 all&46 all‚e e, 6936e, 69364 Lyon64 Lyon Cedex 07, France. vincent.lau-lyon.f  Bernard Lrnard L
         Institut de tut de G‚nomique Fonctionnelle de Lyon; Universit‚ de Liver Universit‚ INRA; EcNRA; Ecole Normale Sup‚rieure deeure de Lyon; 46 all&eacuttalie, 69364 Lyon Cedex 07, Fran7, France. vincent.laudet@ens-lyon.fr
      Zalko D
         Institut de G‚nFonctiononctionnelle de Lyon; Universit‚ de Lyonr Universit‚ LyoRS; ICNRS; INRA; Ermale Supale Sup‚rieure de Lyon; 46 all‚e d'It936e, 69364 Lyon C, France.France. vincent.laudet@ens-lyon.fr
      Cravedi JP
         Instit‚nacute;nomique Fonctionnelle de Lyon; Universit‚ de Lyon; Universit‚ Lyon 1; CNRS; INRA; Ecole Normale Sup‚rieu all&46 all‚e d' 6936e, 69364 Lyon C Lyon Cedex 07, France. vincent.laudeyon.fr
Balaguer P
guer P
         Institut de Gut de G‚nomique Fonctionnelle de Lyon; Universit‚ de Lyver Universit‚ LNRA; EcNRA; Ecole Normale Sup‚rieure deeure de Lyon; 46 all&eacutealie, 69364 Lyon Cedex 07, Franc, France. vincent.laudet@ens-lyon.fr
      Andersson-Lendahl M
         Institut de G‚nomiquiononctionnelle de Lyon; Universit‚ de Lyon; Universit‚ Lyon 1; CNA; Ecole Normale Sup&eacuup‚ri Lyon;  Lyon; 46 all‚e d'It9364 Lyon Cedex 07, France. vince. vincent.laudet@ens-lyon.fr
      Demeneix B
    stitut de G‚nomique Fmique Fonctionnelle de Lyon; Universit‚ de niver Universit‚ Lyon 1; CNRS; INRA; Ecole Normale Sup&eaeure de Lyon; 46 all‚e e, 6alie, 6alie, 69364 Lyon Cedex 07, Francent.lauent.laudet@ens-lyon.fr
      Laudet V
         Institut de G‚nomique Fonctionnelle de Lyon; Universit‚ de Lyver Universit‚ LCNRS; ICNRS; INRA; Ecole Normale Sup‚rieure de Lyoll&eacuItalie, 693ie, 69364 Lyon Cedex 07, Franc, France. vincent.laudet@ens-l

SOURCE:
      BMC DevBMC Dev Biol. 2011, Jan 26; 11:4. [BMC developmental biology]

ABSTRACT:
      BACKGROUND: The plastic monomer and plasticizer bisphenol A (BPA), used
      for manufacturing polycarbonate plastic and epoxy resins, is produced at
      over 2.5 million metric tons per year. Concerns have been raised that BPA
      acts as an endocrine disruptor on both developmental and reproductive
      processes and a large body of evidence suggests that BPA interferes with
      estrogen and thyroid hormone signaling. Here, we investigated BPA effects
      during embryonic development using the zebrafish and Xenopus models.

      RESULTS: We report that BPA exposure leads to severe malformations of the
      otic vesicle. In zebrafish and in Xenopus embryos, exposure to BPA during
      the first developmental day resulted in dose-dependent defects in otolith
      formation. Defects included aggregation, multiplication and occasionally
      failure to form otoliths. As no effects on otolith development were seen
      with exposure to micromolar concentrations of thyroid hormone,
      17-&szlig;-estradiol or of the estrogen receptor antagonist ICI 182,780 we
      conclude that the effects of BPA are independent of estrogen receptors or
      thyroid-hormone receptors. Na+/K+ ATPases are crucial for otolith
      formation in zebrafish. Pharmacological inhibition of the major Na+/K+
      ATPase with ouabain can rescue the BPA-induced otolith phenotype.

      CONCLUSIONS: The data suggest that the spectrum of BPA action is wider
      than previously expected and argue for a systematic survey of the
      developmental effects of this endocrine disruptor.

CAS REGISTRY NUMBERS:
      22X328QOC4
      4TI98Z838E
      5ACL011P69
      EC 3.6.3.9
      MLT3645I99
      QD2C19044Z

LANGUAGE:
      eng

INTERNATIONAL STANDARD SERIAL NUMBER:
      1471-213X (Electronic)

PUBLICATION TYPES:
      Journal Article

ENTRY MONTH:
      201102

TITLE ABBREVIATION:
      BMC Dev Biol

YEAR OF PUBLICATION:
      2011

SECONDARY SOURCE ID:
      Full text: <a href='https://www.ncbi.nlm.nih.gov/pmc/?term=3040707'
      target=new>PMC3040707

LAST REVISION DATE:
      20150205

MEDLINE CITATION:
      NLM

COUNTRY:
      England

CITATION SUBSET:
      IM

MEDLINE TITLE ABBREVIATION:
      BMC developmental biology

ARTICLE DATE:
      20110126

STAT:
      MEDLINE

REFERENCES:
      Cites: Environ Sci Technol. 2002 Oct 15;36(20):4410-5 (medline /12387416)

      Cites: Hum Reprod. 2002 Nov;17(11):2839-41 (medline /12407035)

      Cites: J Clin Endocrinol Metab. 2002 Nov;87(11):5185-90 (medline
      /12414890)

      Cites: Dev Biol. 2005 Sep 1;285(1):138-55 (medline /16231865)

      Cites: Annu Rev Genet. 2005;39:9-22 (medline /16285850)

      Cites: Endocrinology. 2005 Dec;146(12):5388-96 (medline /16123166)

      Cites: Mol Cell Endocrinol. 2005 Dec 1;244(1-2):2-9 (medline /16271281)

      Cites: Dev Biol. 2006 Jun 1;294(1):148-60 (medline /16566913)

      Cites: Brain Res. 2006 May 26;1091(1):58-74 (medline /16529728)

      Cites: PLoS Genet. 2006 Jul;2(7):e102 (medline /16839186)

      Cites: Mol Cell Endocrinol. 2006 Jul 25;254-255:179-86 (medline /16781053)

      Cites: Endocrinology. 2006 Oct;147(10):4941-9 (medline /16825318)

      Cites: Life Sci. 2006 Nov 2;79(23):2165-71 (medline /16905155)

      Cites: Biol Pharm Bull. 2007 Feb;30(2):371-4 (medline /17268083)

      Cites: Development. 2007 Jul;134(13):2449-58 (medline /17522161)

      Cites: PLoS One. 2007;2(6):e525 (medline /17565378)

      Cites: Environ Health Perspect. 2007 Jun;115(6):902-8 (medline /17589598)

      Cites: Reprod Toxicol. 2007 Aug-Sep;24(2):225-39 (medline /17604601)

      Cites: Reprod Toxicol. 2007 Aug-Sep;24(2):178-98 (medline /17628395)

      Cites: Environ Sci Technol. 2007 Aug 15;41(16):5908-14 (medline /17874805)

      Cites: Gene Expr Patterns. 2008 Feb;8(3):141-7 (medline /18178530)

      Cites: Dev Neurobiol. 2008 Feb 1;68(2):209-22 (medline /18000829)

      Cites: Endocr J. 1999 Dec;46(6):773-8 (medline /10724352)

      Cites: Environ Sci Technol. 2001 Aug 1;35(15):3201-6 (medline /11506003)

      Cites: Chemosphere. 2001 Nov;45(4-5):535-41 (medline /11680749)

      Cites: Ann N Y Acad Sci. 2001 Oct;942:162-78 (medline /11710459)

      Cites: Biochem Biophys Res Commun. 2002 Feb 15;291(1):76-8 (medline
      /11829464)

      Cites: Environ Toxicol. 2002 Feb;17(1):80-6 (medline /11847978)

      Cites: Neoplasia. 2002 Mar-Apr;4(2):98-102 (medline /11896564)

      Cites: Environ Sci Technol. 2002 Mar 15;36(6):1202-11 (medline /11944670)

      Cites: Biol Reprod. 2002 Jun;66(6):1881-92 (medline /12021076)

      Cites: J Mol Endocrinol. 2002 Jun;28(3):153-63 (medline /12063182)

      Cites: Chemosphere. 2002 Oct;49(1):61-73 (medline /12243331)

      Cites: Chemosphere. 2002 Oct;49(1):97-103 (medline /12243336)

      Cites: Environ Toxicol. 2008 Feb;23(1):15-24 (medline /18214933)

      Cites: Reprod Toxicol. 2008 Feb;25(2):177-83 (medline /18191535)

      Cites: PLoS Genet. 2007 Nov;3(11):e188 (medline /17997606)

      Cites: J Clin Invest. 2008 Apr;118(4):1563-70 (medline /18317592)

      Cites: Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):157-395
      (medline /18613034)

      Cites: Sci Total Environ. 2008 Sep 1;402(2-3):201-16 (medline /18433838)

      Cites: Mol Cell Endocrinol. 2008 Oct 10;293(1-2):5-16 (medline /18634845)

      Cites: Toxicol In Vitro. 2008 Oct;22(7):1697-704 (medline /18672047)

      Cites: Nature. 2009 Jan 8;457(7226):205-9 (medline /19043402)

      Cites: PLoS One. 2009;4(3):e4935 (medline /19319186)

      Cites: Toxicol Sci. 2009 Apr;108(2):344-55 (medline /19218331)

      Cites: Food Chem Toxicol. 2004 Jun;42(6):983-93 (medline /15110108)

      Cites: Endocrinology. 2009 Jun;150(6):2964-73 (medline /19228888)

      Cites: Ecotoxicol Environ Saf. 2008 Nov;71(3):774-80 (medline /18359083)

      Cites: Development. 2003 Apr;130(7):1403-17 (medline /12588855)

      Cites: Environ Health Perspect. 2003 Mar;111(3):309-19 (medline /12611660)

      Cites: Dev Dyn. 2003 Jul;227(3):422-30 (medline /12815629)

      Cites: Dev Dyn. 2003 Nov;228(3):386-92 (medline /14579377)

      Cites: Development. 2004 Feb;131(4):943-51 (medline /14736743)

      Cites: Mar Pollut Bull. 2004 Jun;48(11-12):1161-7 (medline /15172824)

      Cites: Dev Dyn. 2004 Jul;230(3):419-33 (medline /15188428)

      Cites: Science. 2004 Jul 16;305(5682):404-7 (medline /15256672)

      Cites: Biomed Chromatogr. 2004 Oct;18(8):501-7 (medline /15386523)

      Cites: Development. 1993 Dec;119(4):1203-15 (medline /8306883)

      Cites: Dev Dyn. 1995 Jul;203(3):253-310 (medline /8589427)

      Cites: J Comp Neurol. 1996 Jan 29;365(1):113-28 (medline /8821445)

      Cites: Development. 1996 Dec;123:241-54 (medline /9007244)

      Cites: Dev Biol. 1997 Nov 15;191(2):191-201 (medline /9398434)

      Cites: Front Neuroendocrinol. 1998 Oct;19(4):253-86 (medline /9799586)

      Cites: J Endocrinol. 1998 Sep;158(3):R11-4 (medline /9846177)

      Cites: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15758-62 (medline
      /9861043)

      Cites: Environ Health Perspect. 1998 Mar;106(3):167-74 (medline /9449681)

      Cites: J Clin Invest. 1999 Aug;104(3):291-300 (medline /10430610)

      Cites: Endocrinology. 2005 Feb;146(2):607-12 (medline /15498886)

      Cites: Mol Endocrinol. 2005 Apr;19(4):833-42 (medline /15695368)

      Cites: Environ Health Perspect. 2005 Apr;113(4):391-5 (medline /15811827)

      Cites: Environ Health Perspect. 2005 Apr;113(4):431-9 (medline /15811834)

      Cites: Mol Cell Endocrinol. 2005 Oct 20;242(1-2):10-5 (medline /16150534)

DOCUMENT NUMBER:
      medline/21269433

4 - DART
TITLE:
      Structural bisphenol analogues differentially target steroidogenesis in
      murine MA-10 Leydig cells as well as the glucocorticoid receptor.

AUTHORS:
      Roelofs MJ
         Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands; Center for Health Protection, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: m.j.e.roelofs@uu.nl.
      van den Berg M
         Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
      Bovee TF
         RIKILT-Institute of Food Safety, Wageningen University and Research Centre, Akkermaalsbos 2, 6708 WB Wageningen, The Netherlands.
      Piersma AH
         Center for Health Protection, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands; Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
      van Duursen MB
         Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.

SOURCE:
      Toxicology. 2015, Mar 02; 329:10-20. [Toxicology]

ABSTRACT:
      Although much information on the endocrine activity of bisphenol A (BPA)
      is available, a proper human hazard assessment of analogues that are
      believed to have a less harmful toxicity profile is lacking. Here the
      possible effects of BPA, bisphenol F (BPF), bisphenol S (BPS), as well as
      the brominated structural analogue and widely used flame retardant
      tetrabromobisphenol A (TBBPA) on human glucocorticoid and androgen
      receptor (GR and AR) activation were assessed. BPA, BPF, and TBBPA showed
      clear GR and AR antagonism with IC50 values of 67 &mu;M, 60 &mu;M, and 22
      nM for GR, and 39 &mu;M, 20 &mu;M, and 982 nM for AR, respectively,
      whereas BPS did not affect receptor activity. In addition, murine MA-10
      Leydig cells exposed to the bisphenol analogues were assessed for changes
      in secreted steroid hormone levels. Testicular steroidogenesis was altered
      by all bisphenol analogues tested. TBBPA effects were more directed
      towards the male end products and induced testosterone synthesis, while
      BPF and BPS predominantly increased the levels of progestagens that are
      formed in the beginning of the steroidogenic pathway. The MA-10 Leydig
      cell assay shows added value over the widely used H295R steroidogenesis
      assay because of its fetal-like characteristics and specificity for the
      physiologically more relevant testicular &Delta;4 steroidogenic pathway.
      Therefore, adding an in vitro assay covering fetal testicular
      steroidogenesis, such as the MA-10 cell line, to the panel of tests used
      to screen potential endocrine disruptors, is highly recommendable.

KEYWORDS:
      (Fetal-like) steroidogenesis
      (Structural) bisphenol analogues (TBBPA, BPA, BPF, BPS)
      Androgen receptor (AR)
      Glucocorticoid receptor (GR)
      Murine MA-10 Leydig cells
      Testosterone (T)

CAS REGISTRY NUMBERS:
      3XMK78S47O
      80-09-1
      FQI02RFC3A
      MLT3645I99

LANGUAGE:
      eng

INTERNATIONAL STANDARD SERIAL NUMBER:
      1879-3185 (Electronic)

PUBLICATION TYPES:
      Journal Article

      Research Support, Non-U.S. Gov't

ENTRY MONTH:
      201502

TITLE ABBREVIATION:
      Toxicology

YEAR OF PUBLICATION:
      2015

LAST REVISION DATE:
      20150216

COPYRIGHT INFORMATION:
      Copyright &copy; 2015 Elsevier Ireland Ltd. All rights reserved.

MEDLINE CITATION:
      NLM

COUNTRY:
      Ireland

CITATION SUBSET:
      IM

MEDLINE TITLE ABBREVIATION:
      Toxicology

ARTICLE DATE:
      20150108

STAT:
      MEDLINE

DOCUMENT NUMBER:
      medline/25576683
